Targeted Clinical Research to Address Select Viral Infections-An Adaptive Pharmacokinetic, Pharmacodynamic, Concentration Response Investigation of CMX-001 in the Infants with Neonatal Herpes (HSV) Followed by Randomized Assessment

Grant

Date/time Interval

  • September 28, 2011 - August 15, 2020
  • Total Award Amount

  • 4147534.00
  • Direct Costs

  • 3068192.00
  • Sponsor Award Id

  • HHSN272201100038C
  • Contributor

  • Cutter, Gary   Investigator  
  • Whitley M.D., Richard   Principal Investigator